Studies on the intestinal microbiota have shown an inverse relationship between microbiota diversity and neurological disorders, a reduction in Bacteroidetes , and reduced expression of TJ proteins in the intestinal mucosa [95, 113,114,115]
Drug Reactions BPC-157 has been shown to reduce the adverse effects of NSAIDs, psychiatric drugs, and several cardiac treatments
Wang G-E, Li Y-F, Zhai Y-J, Gong L, Tian J-Y, Hong M, et al
Short-term safety profile (up to 68 weeks) shows side effects consistent with other incretin medications plus a new signal for dysesthesia
The active component Procyanidins is administered to Wistar rats at a dose of 500 mg/kg for research purposes, resulting in an increase in plasma GLP-1 levels in rats [19]